| Literature DB >> 24727902 |
Abstract
The addition of polysialic acid to proteins and cells is emerging as a promising therapeutic strategy. Polysialyltransferases synthesize polymers of widely varying lengths not optimal for therapeutic reagents, but the development of enzyme variants using neutral genetic drift offers a new way to overcome this problem.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24727902 DOI: 10.1038/nchembio.1506
Source DB: PubMed Journal: Nat Chem Biol ISSN: 1552-4450 Impact factor: 15.040